Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

Frank V. Fossella, Jose R. Pereira, Joachim von Pawel et al. · Journal of Clinical Oncology · 2003 · 943 citations

Medicine, Oncology, Pharmacology +15

Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.

Mei-Ling Shen, I M Jones, H.W. Mohrenweiser · PubMed · 1998 · 774 citations

Life Sciences, Genetics, Molecular Genetics +17

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

Medicine, Molecular Biology, Oncology +14

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene<i>ABCB1</i>

Asra Tus Saleha Siddiqui, Reinhold Kerb, Michael E. Weale et al. · New England Journal of Medicine · 2003 · 652 citations · Full text

Medicine, Molecular Genetics, Pharmacology +17